Taiwan FDA registration af7b00ad723ba5e16d2acd0a9dea70aa
"Response Biomedical" RSV Rapid Test (non-sterile)
TW: "瑞邦生醫" 呼吸道融合細胞病毒快速檢驗試劑 (未滅菌)
Taiwan·Risk Class 1·MD·RESPONSE BIOMEDICAL CORPORATION·Registered Jan 05, 2016 – Jan 05, 2021ExpiredRegistration details
- Analysis ID
- af7b00ad723ba5e16d2acd0a9dea70aa
- License Form
- Ministry of Health Medical Device Import No. 016044
- Customs Code
- DHA09401604403
Company information
- Manufacturer
- RESPONSE BIOMEDICAL CORPORATION
- Manufacturer Country
- Canada
- Authorized Representative
- RECHI CO., LTD.
Product details
- Intended Use
- Limited to the first level identification range of the Measures for the Administration of Medical Devices "Respiratory Fusion Cell Virus Serological Reagent (C.3480)".
- Product Type (Level 1)
- C Immunology and microbiology devices
- Product Type (Level 2)
- C3480 Respiratory Fusion Cell Virus Serological Reagent
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jan 05, 2016
- Expiry Date
- Jan 05, 2021
About this record
Access comprehensive regulatory information for "Response Biomedical" RSV Rapid Test (non-sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number af7b00ad723ba5e16d2acd0a9dea70aa and manufactured by RESPONSE BIOMEDICAL CORPORATION. The authorized representative in Taiwan is RECHI CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices